Invention Grant
- Patent Title: Pharmaceutical compositions comprising glitazones and Nrf2 activators
-
Application No.: US18049652Application Date: 2022-10-26
-
Publication No.: US12083107B2Publication Date: 2024-09-10
- Inventor: Bjoern Colin Kahrs
- Applicant: Bjoern Colin Kahrs
- Applicant Address: CH Brissago
- Assignee: Bjoern Colin Kahrs
- Current Assignee: Bjoern Colin Kahrs
- Current Assignee Address: CH Brissago
- Agency: SALIWANCHIK, LLOYD & EISENSCHENK
- Priority: EP 194292 2011.12.19 EP 004652 2012.06.21
- Main IPC: A61K31/05
- IPC: A61K31/05 ; A61K9/00 ; A61K31/12 ; A61K31/16 ; A61K31/19 ; A61K31/216 ; A61K31/225 ; A61K31/26 ; A61K31/385 ; A61K31/426 ; A61K31/4439 ; A61K31/47 ; A61P1/04 ; A61P5/48 ; A61P11/00 ; A61P11/06 ; A61P13/12 ; A61P17/00 ; A61P17/06 ; A61P17/14 ; A61P19/02 ; A61P21/02 ; A61P21/04 ; A61P25/00 ; A61P25/14 ; A61P25/16 ; A61P25/28 ; A61P29/00 ; A61P37/06 ; A61P43/00
Abstract:
The invention relates to pharmaceutical compositions comprising PPAR agonists and Nrf2 activators and methods of using combinations of PPAR agonists and Nrf2 activators for treating diseases such as psoriasis, asthma, multiple sclerosis, inflammatory bowel disease, and arthritis.
Public/Granted literature
- US20230190720A1 PHARMACEUTICAL COMPOSITIONS COMPRISING GLITAZONES AND NRF2 ACTIVATORS Public/Granted day:2023-06-22
Information query
